ZS Advances Agentic AI Applications for Life Sciences With Launch of ZAIDYN Medical™ and ZAIDYN Content™

Building on decades of life sciences expertise, ZS is scaling agentic AI from strategy to governed execution across medical and commercial workflows.

EVANSTON, Ill.--(BUSINESS WIRE)--ZS, a global management consulting and technology firm, today announced its expansion of ZAIDYN^®, a life sciences intelligence platform powered by agentic AI. The expansion introduces ZAIDYN Medical™ and ZAIDYN Content™—two new purpose-built, modular application suites that combine deep domain expertise with data, advanced analytics and AI to address specific business challenges. Together, these launches reflect ZS’s leadership in applying agentic AI to regulated, high-stakes workflows, helping life sciences organizations accelerate decisions and support execution with the governance, scientific rigor and compliance the industry demands.

ZAIDYN makes decision-ready intelligence actionable—safely, at scale and embedded into how teams work. ZAIDYN has specialized agents that monitor signals, recommend next best actions and execute governed workflows with human review, approval and override at every step. Building on the foundation of ZAIDYN Commercial, ZAIDYN Medical and ZAIDYN Content bring agentic AI into medical intelligence and the compliant content supply chain through a shared intelligence layer, so leaders can move faster, confidently and consistently.

“ZS has spent decades helping life sciences teams solve their most complex commercial and medical challenges, and now we’re packaging that expertise with agentic AI in our products,” said Sunil Dixit, chief product officer at ZS. “We built these new product lines to address the pressure on life sciences organizations to do more with less. Agents grounded in domain and armed with rich ontologies can support and streamline medical, legal and regulatory (MLR) review workflows and deliver insights to medical affairs teams to help accelerate the speed of their work.”

ZAIDYN Medical

ZAIDYN Medical is backed by ZS’s extensive innovation and intellectual property portfolio, including issued U.S. patents and pending patent applications focused on AI-driven medical intelligence. Within the suite, ZAIDYN OLI™ includes capabilities related to technologies described in a recently granted U.S. patent, highlighting ZS’s innovation in AI-driven opinion leader and influence network intelligence for life sciences.

ZAIDYN Medical helps medical affairs teams identify, prioritize and engage key opinion leaders while generating end-to-end insights 50-70% faster. The platform also includes capabilities that help teams identify care gaps, measure patient outcomes, generate scientific and stakeholder insights, and support compliant medical engagement.

“Medical affairs teams are under increasing pressure to focus their time and attention where it matters most,” said Murali Gopal, MD, senior vice president and head of medical affairs at Ardelyx, Inc. “Approaches that help teams prioritize stakeholders and prepare for scientific engagement more effectively can support more focused conversations and greater continuity across interactions.”

ZAIDYN Content

ZAIDYN Content is a purpose-built, flexible agentic AI suite designed to accelerate the life sciences content supply chain from creation through MLR approval and reuse. Its Content MLR Accelerator module embeds compliance, brand and medical intelligence directly into review workflows, helping teams improve submission readiness, streamline reviews and scale compliant content reuse and localization without increasing risk.

ZAIDYN Content also supports content generation and personalization, enabling faster, compliant content reuse across brands, markets and languages. Deployed at enterprise scale, ZAIDYN Content has expedited more than 100,000 assets across brands, markets and languages, reducing cycle time for personalized and derivative content by over 67%.

“The true value of innovation in life sciences is realized when it reaches the people who need it,” said Jaideep Bajaj, chairman at ZS. “ZAIDYN Content helps organizations deliver important information to patients, providers and stakeholders with greater speed, supporting meaningful impact for all.”

Additional information about ZAIDYN is available at ZAIDYN.ai.